Current Pharmacogenomics


Adrián LLerena , MD, Ph.D
Extremadura University
Hospital and Medical School
Badajoz, Extremadura


Cancer Pharmacogenomics: Germline DNA, Tumor DNA, or Both?

Volume:5   Issue: 2
Pp: 87-101
E. Cerri, A. Falcone and F. Innocenti
DOI: 10.2174/157016007780831781

Clinical Significance of Thiopurine S-Methyltransferase Gene Polymorphisms

Volume:5   Issue: 2
Pp: 103-115
Shu-Feng Zhou and Balram Chowbay
DOI: 10.2174/157016007780831808

Pharmacogenomics in Colorectal Cancer

Volume:5   Issue: 2
Pp: 117-123
F. Meriggi, B. Di Biasi, C. Caliolo and A. Zaniboni
DOI: 10.2174/157016007780831790

Genetics and the Mechanisms of Action of Inhaled Anesthetics

Volume:5   Issue: 2
Pp: 125-141
Louise M. Steele, Phil G. Morgan and Margaret M. Sedensky
DOI: 10.2174/157016007780831763

Pharmacogenetics of Oxazaphosphorines and its Clinical Implications

Volume:5   Issue: 2
Pp: 143-156
Shu-Feng Zhou, Balram Chowbay and Charlie Changli Xue
DOI: 10.2174/157016007780831754

Structural and Functional Organization of miRNAs

Volume:5   Issue: 2
Pp: 157-166
E. Enerly, R. Sachidanandam, D. K. Pant, A. L. Borresen-Dale and V. N. Kristensen
DOI: 10.2174/157016007780831772